What are the indications for Pitobrutinib? What specific types of diseases does it work for?

Pirtobrutinib is a targeted drug that is a Bruton's tyrosine kinase (BTK) inhibitor and is mainly used to treat some hematological malignancies. It effectively blocks the growth and survival of tumor cells by selectively inhibiting BTK and interfering with the BCR (BCR) signaling pathway. The therapeutic effect of pitobrutinib is mainly reflected in the treatment of specific types of malignant tumors such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and non-Hodgkin lymphoma (NHL).

Pitobrutinib is approved to treat chronic lymphocytic leukemia (CLL), particularly in patients who are resistant to or have relapsed with other treatments. CLL is a blood cancer characterized by the proliferation of abnormal B cells, often accompanied by impaired immune system function. Pitobrutinib inhibits BTK and reduces the activation and proliferation of B cells, thereby effectively controlling tumor progression. It is especially suitable for patients who cannot receive chemotherapy.

Pitobrutinib is also indicated for the treatment of small lymphocytic lymphoma (SLL). SLL is a subtype of CLL and has similar biological characteristics, but is mainly characterized by enlarged lymph nodes. Due to BTK's key role in B cell activation and growth, pitobrutinib can effectively inhibit the proliferation of SLL cells by inhibiting BTK signaling and alleviate the condition of patients, especially those with existing treatment resistance.

Pittobrutinib has also shown potential in the treatment of non-Hodgkin lymphoma (NHL). Non-Hodgkin's lymphoma is a type of malignant tumor originating from BB cells, including multiple subtypes, such as diffuse large B cell lymphoma. Pitobrutinib can inhibitBTK by targeting, reducing the growth and spread of tumor cells, especially for patients who are ineffective in traditional treatments, providing these patients with new treatment options.

Reference materials:https://www.jaypirca.com/